WuXi's STA Pharma Begins Work On China Plant To Quadruple Capacity
This article was originally published in PharmAsia News
Executive Summary
WuXi Pharma Tech's Syn-The-All Pharmaceuticals unit has begun construction of a drug-production plant near Shanghai to help the parent company meet a demand for its services that has quadrupled the past four years.